Cadd, Sharon
Cadd, Sharon was paid $6K by Medicaid between Jul 2023 and Jul 2023, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoCADD, SHARON
LEXINGTON, VA 24450
LEXINGTON, VA 24450
33aNPI1831627512assigned 05/25/2017
33bProvider typeRegistered Nurse
28Total paid$6K
24GClaims93
24DCodes billed5
24AFirst – last monthJul 2023 – Jul 2023
Compared with peers
Next to other Registered Nurse providers in Virginia
Rank by total paid#18 of 35
Median peer was paid$6K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 93 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 34 | 32 | $3K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 37% | 15 | 14 | $2K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 15 | 15 | $936.14 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 14 | 14 | $158.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | 14 | $30.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.